During the past decade, Columbia Saint Mary's Water Tower Medical Commons conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 14 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbia Saint Mary's Water Tower Medical Commons" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "NRG Oncology" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia Saint Mary's Water Tower Medical Commons" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Columbia Saint Mary's Water Tower Medical Commons" are "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials), "Neurotoxicity Syndrome" (2 trials), "Recurrent Non-Small Cell Lung Carcinoma" (2 trials) and "Adenosquamous Lung Carcinoma" (1 trials). Many other conditions were trialed in "Columbia Saint Mary's Water Tower Medical Commons" in a lesser frequency.

Most popular intervention types in "Columbia Saint Mary's Water Tower Medical Commons" are "Drug" (17 trials), "Other" (10 trials), "Radiation" (7 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Carboplatin" (5 trials), "Paclitaxel" (5 trials), "Quality-of-Life Assessment" (5 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Columbia Saint Mary's Water Tower Medical Commons" are 12 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Columbia Saint Mary's Water Tower Medical Commons". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Columbia Saint Mary's Water Tower Medical Commons, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia Saint Mary's Water Tower Medical Commons, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".